US HB7248 | 2023-2024 | 118th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on February 6 2024 - 25% progression
Action: 2024-02-09 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 6 2024 - 25% progression
Action: 2024-02-09 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to establish a process for the qualification of nonclinical testing methods to reduce and replace the use of animals in nonclinical research, improve the predictivity of nonclinical testing methods, and reduce development time for a biological product or other drug, and for other purposes.
Title
FDA Modernization Act 3.0
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2024-02-09 | House | Referred to the Subcommittee on Health. |
| 2024-02-06 | House | Referred to the House Committee on Energy and Commerce. |
| 2024-02-06 | House | Introduced in House |
Same As/Similar To
SB5046 (Related) 2024-12-16 - Held at the desk.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/house-bill/7248/all-info |
| Text | https://www.congress.gov/118/bills/hr7248/BILLS-118hr7248ih.pdf |
